Type 1 Diabetes May Cause False-Positive Celiac Blood Tests, Complicating Screening in Children

Children and adults with type 1 diabetes (搜索)搜索该疾病 are routinely screened for celiac disease (搜索)搜索该疾病 because the two autoimmune conditions occur together more often than would be expected by chance. However, emerging clinical guidance highlights a difficult complication: the blood test most commonly used to detect celiac disease may not be as straightforward in people with type 1 diabetes. New guidance warns that type 1 diabetes itself can be associated with temporary increases in tissue transglutaminase antibodies, particularly around the time diabetes is diagnosed—the same antibodies used as the first screening test for celiac disease.

This means a positive result in someone with type 1 diabetes (搜索)搜索该疾病 may indicate genuine celiac disease (搜索)搜索该疾病, but it may also represent a temporary autoimmune response that does not correspond to the intestinal damage required for a confirmed celiac diagnosis.

A Pediatric Study Found Frequent Celiac Positivity

A recent retrospective study reviewed the medical records of 407 children and adolescents with type 1 diabetes (搜索)搜索该疾病 who received care at King Saud Hospital in Unaizah, in the Qassim region of Saudi Arabia. The patients ranged from two to 17 years old, with an average current age of about 12 years and an average diabetes diagnosis age of approximately eight years.

The researchers examined diabetes control along with several conditions that commonly accompany type 1 diabetes (搜索)搜索该疾病, including thyroid disorders, abnormal blood fats, vitamin D deficiency, kidney involvement, eye disease, and celiac disease (搜索)搜索该疾病. Celiac information was available for only 95 of the 407 patients. Among those 95 children, 13 were recorded as celiac-positive, producing a rate of 13.7 percent among the patients for whom this information was available.

That figure appears high, but it requires careful interpretation. The study did not clearly establish in its reported results whether every positive child had celiac disease (搜索)搜索该疾病 confirmed through intestinal biopsies, whether the finding was based only on celiac antibodies, or whether some cases had been diagnosed through other clinical pathways. The study therefore supports the importance of screening children with type 1 diabetes (搜索)搜索该疾病, but it does not prove that 13.7 percent of the full diabetes population had biopsy-confirmed celiac disease.

Why the Two Conditions Often Appear Together

Type 1 diabetes (搜索)搜索该疾病 and celiac disease (搜索)搜索该疾病 are both autoimmune conditions. In type 1 diabetes, the immune system attacks the insulin-producing cells of the pancreas. In celiac disease, gluten exposure triggers an immune response that damages the lining of the small intestine. The two diseases share important genetic risk factors, and having type 1 diabetes genuinely raises the likelihood of also developing celiac disease.

Because celiac disease (搜索)搜索该疾病 can be silent, screening cannot be limited to children who report diarrhea, stomach pain, or weight loss. A child with diabetes and celiac disease may have no obvious digestive symptoms. Others may experience poor growth, delayed puberty, iron deficiency, unexplained fatigue, unstable blood sugar, constipation, or reduced bone health. Routine screening remains necessary; the challenge is making sure a positive screening result is interpreted correctly rather than treated as automatic proof of celiac disease.

What Tissue Transglutaminase Antibodies Normally Tell Doctors

The immunoglobulin A tissue transglutaminase antibody (搜索)搜索该靶点 test is generally the first blood test ordered when celiac disease (搜索)搜索该疾病 is suspected. In the general population, it is highly sensitive, meaning it identifies most people who truly have the disease. Very high levels—particularly results at least 10 times the laboratory's upper limit of normal—are strongly associated with celiac disease in appropriate clinical settings, and some diagnostic pathways allow selected patients with extremely high levels to be diagnosed without an intestinal biopsy.

However, the predictive value of any test depends on the population being tested and on whether other illnesses can produce the same laboratory abnormality. Type 1 diabetes (搜索)搜索该疾病 presents a special problem because it may cause tissue transglutaminase antibodies to rise without producing the intestinal changes of celiac disease (搜索)搜索该疾病. Autoimmune activity surrounding the onset of diabetes may temporarily stimulate these antibodies, after which the levels may decline or disappear while the person continues eating gluten.

A Positive Screening Test Is Not Always a Confirmed Diagnosis

The updated British Society of Gastroenterology guidance lists type 1 diabetes (搜索)搜索该疾病 among the autoimmune conditions that can produce false-positive celiac serology. It also notes that temporary tissue transglutaminase antibody (搜索)搜索该靶点 increases can occur around the time type 1 diabetes is diagnosed. This does not mean celiac blood tests are useless in people with diabetes; it means their results may need more context and confirmation.

A mildly elevated antibody level is especially different from an extremely elevated result. A low positive result may normalize during repeat testing, while a persistently high or rising result is more concerning for true celiac disease (搜索)搜索该疾病. Other information can help clarify the picture, including whether the antibody remains elevated on repeat testing, how far the result is above the laboratory's normal limit, whether endomysial antibodies are also present, whether the person has a normal total immunoglobulin A level, whether symptoms or nutritional deficiencies are present, whether intestinal biopsies show changes consistent with celiac disease, and whether the person carries genetic types associated with celiac disease.

Why the Timing of Screening May Matter

A child newly diagnosed with type 1 diabetes (搜索)搜索该疾病 is experiencing major metabolic and immune disruption. Blood sugar may be extremely high, insulin production has fallen, and the body may be recovering from severe illness or diabetic ketoacidosis. If tissue transglutaminase antibodies are checked during this period and are only modestly elevated, the result may not have the same meaning as a persistent elevation found months later.

This raises the possibility that the positive predictive value of celiac serology is lower near the onset of type 1 diabetes (搜索)搜索该疾病 than it is in otherwise healthy people being evaluated for celiac disease (搜索)搜索该疾病. The pediatric study did not directly test this theory because it did not compare antibody levels with biopsy results over time. The newer diagnostic guidance, however, recognizes transient antibody elevation as a real source of diagnostic uncertainty.

Why Starting a Gluten-Free Diet Too Soon Can Cause Problems

Families may understandably want to remove gluten immediately after receiving a positive blood test. However, beginning a gluten-free diet before the diagnosis is clarified can make later testing much more difficult. Celiac blood tests and intestinal biopsy findings depend on continued gluten consumption. Once gluten is removed, antibody levels may decline and the small intestine may begin to heal, and a child may then need to resume eating gluten for weeks before accurate testing can be completed.

A premature diagnosis also creates a substantial lifelong burden. Managing type 1 diabetes (搜索)搜索该疾病 already requires continuous attention to insulin, carbohydrates, blood sugar, exercise, illness, and the risk of low blood sugar. Adding a strict gluten-free diet affects school meals, restaurants, travel, family cooking, social events, and food costs. That burden is justified when celiac disease (搜索)搜索该疾病 is present, but it should not be imposed solely because of a temporary or weakly positive screening result without appropriate clinical review.

Genuine Celiac Disease Must Still Be Taken Seriously

The possibility of false-positive antibodies should not be used as a reason to dismiss celiac screening in people with type 1 diabetes (搜索)搜索该疾病. True celiac disease (搜索)搜索该疾病 is substantially more common in this group than in the general population. Untreated celiac disease can interfere with nutrient absorption, growth, bone development, and overall health, and it may complicate diabetes management by making carbohydrate absorption less predictable.

Some patients experience fewer episodes of unexplained low blood sugar after celiac disease (搜索)搜索该疾病 is diagnosed and treated, although diabetes responses vary. A strict gluten-free diet is necessary for those with confirmed celiac disease even when they have no obvious digestive symptoms. The goal is not to reduce screening, but to make screening more accurate by distinguishing children who truly have celiac disease from those experiencing temporary antibody elevation related to type 1 diabetes (搜索)搜索该疾病 or another autoimmune process.

Important Limits of the Pediatric Study

The Saudi study was conducted at a single medical center and relied on existing medical records. Many records were incomplete, and the number of patients with documented results varied widely from one condition to another. Although the study included 407 patients, celiac status was recorded for only 95, meaning the reported 13.7 percent positivity rate came from less than one-quarter of the full group.

The children who received celiac testing may also have differed from those who were not tested. Some may have been screened routinely, while others may have been tested because they had symptoms, poor growth, unstable diabetes, or another reason for suspicion, which could make the rate among tested children higher than the rate in the complete population. Most importantly, the study described celiac positivity but did not provide enough detail to determine the positive predictive value of the screening test. It cannot tell how many antibody-positive children had biopsy-confirmed intestinal damage, how high their antibody levels were, or how many later became antibody-negative without adopting a gluten-free diet.

What This Means for Patients and Clinicians

For people with confirmed celiac disease (搜索)搜索该疾病, this research does not weaken the diagnosis or change the need for a strict gluten-free diet. When celiac antibodies, clinical findings, and intestinal damage align, the diagnosis remains well supported. The findings are most relevant to people with type 1 diabetes (搜索)搜索该疾病 who have newly positive or mildly elevated celiac antibodies but have not yet received a definitive diagnosis.

Those patients should not assume that the result is meaningless, but they also should not assume it proves celiac disease (搜索)搜索该疾病. Repeat blood testing, specialist evaluation, and sometimes intestinal biopsies may be needed, especially when antibody levels are not extremely high or when test results conflict. People with non-celiac gluten sensitivity face a different issue: there is no validated blood test that confirms gluten sensitivity, and tissue transglutaminase antibodies are not used to diagnose it. A person with diabetes who has symptoms after eating gluten still needs a proper celiac evaluation before removing gluten, because starting the diet early can obscure the diagnosis.

Children with type 1 diabetes (搜索)搜索该疾病 have a genuine increased risk of celiac disease (搜索)搜索该疾病 and should continue to receive appropriate screening. However, the same autoimmune activity associated with diabetes may temporarily raise tissue transglutaminase antibodies, particularly near the time diabetes is diagnosed. A positive screening test should be treated as a reason for further evaluation rather than automatic proof of celiac disease. The most responsible approach combines antibody levels, repeat testing, symptoms, nutritional findings, genetic information when useful, and intestinal biopsies when necessary—helping to identify genuine celiac disease without placing children and families on an unnecessary lifelong gluten-free diet based on a potentially temporary blood-test abnormality.